Black Diamond Therapeutics, Inc. - COM (BDTX)

Historical Portfolio Holders from Q1 2020 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
46.5M
Holdings value Q2 2024
$217M
Value change Q2 2024
+$31.8M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
87
Number of buys Q2 2024
55
Number of sells Q2 2024
-45
Average buys Q2 2024 %
+0.001%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 10K $43.5K -$64.5K $4.35 1
2024 Q2 46.5M $217M +$31.8M $4.66 87
2024 Q1 39.2M $199M +$9.28M $5.07 85
2023 Q4 38.1M $107M +$4.41M $2.81 73
2023 Q3 37.2M $107M -$21.9M $2.87 70
2023 Q2 41.4M $209M +$105M $5.05 72
2023 Q1 21.5M $40.6M +$847K $1.89 46
2022 Q4 21.1M $37.9M -$722K $1.80 55
2022 Q3 21.5M $36.3M -$285K $1.69 56
2022 Q2 21.5M $52.9M -$3.55M $2.46 55
2022 Q1 22.9M $64.1M -$2.43M $2.77 69
2021 Q4 23.2M $124M -$13M $5.33 82
2021 Q3 24.4M $206M -$11.2M $8.46 88
2021 Q2 25.4M $310M -$81.4M $12.19 96
2021 Q1 29.1M $706M -$7.56M $24.26 108
2020 Q4 28.6M $917M +$140M $32.05 109
2020 Q3 23.8M $718M +$754K $30.23 88
2020 Q2 22.8M $959M +$39.9M $42.16 79
2020 Q1 22.3M $555M +$555M $24.95 65